CL2008002861A1 - Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion. - Google Patents
Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion.Info
- Publication number
- CL2008002861A1 CL2008002861A1 CL2008002861A CL2008002861A CL2008002861A1 CL 2008002861 A1 CL2008002861 A1 CL 2008002861A1 CL 2008002861 A CL2008002861 A CL 2008002861A CL 2008002861 A CL2008002861 A CL 2008002861A CL 2008002861 A1 CL2008002861 A1 CL 2008002861A1
- Authority
- CL
- Chile
- Prior art keywords
- polypeptide
- conjugated molecule
- cell
- polypeptides
- peptides
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 14
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 14
- 229920001184 polypeptide Polymers 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 241001109650 Micromonospora ruminantium Species 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 230000000696 methanogenic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 4
- 230000000813 microbial effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- -1 POLIPEPTIDES Proteins 0.000 abstract 1
- 210000003850 cellular structure Anatomy 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/641—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
- Y02P60/22—Methane [CH4], e.g. from rice paddies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
Abstract
COMPONENTES DE CÉLULAS MICROBIANAS QUE SON ÚTILES PARA PRODUCCIÓN DE ANTICUERPOS, INCLUYENDO PÉPTIDOS, POLIPÉPTIDOS QUE COMPRENDEN ESTOS PÉPTIDOS, POLINUCLEÓTIDOS QUE CODIFICAN ESTOS PÉPTIDOS O POLIPÉPTIDOS, Y ANTICUERPOS DIRIGIDOS A ESTOS PÉPTIDOS, POLIPÉPTIDOS O POLINUDEÓTIDOS. VECTORES DE EXPRESIÓN Y CÉLULAS HUÉSPED PARA PRODUCIR ESTOS PÉPTIDOS, POLIPÉPTIDOS, POLINUCLEÁTIDOS Y ANTICUERPOS. MÉTODOS Y COMPOSICIONES, ESPECIALMENTE COMPOSICIONES DE VACUNAS, PARA DETECTAR, DIRIGIR E INHIBIR CÉLULAS MICROBIANAS, ESPECIALMENTE CÉLULAS METANÓGENAS, USANDO UNO O MÁS DE LOS PÉPTIDOS, POLIPÉPTIDOS, POLINUCLEÓTIDOS, ANTICUERPOS, VECTORES DE EXPRESIÓN Y CÉLULAS HUÉSPED REVELADOS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97510407P | 2007-09-25 | 2007-09-25 | |
US98984007P | 2007-11-22 | 2007-11-22 | |
US98984107P | 2007-11-22 | 2007-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008002861A1 true CL2008002861A1 (es) | 2009-03-06 |
Family
ID=40511642
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008002861A CL2008002861A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion. |
CL2008002859A CL2008002859A1 (es) | 2007-09-25 | 2008-09-25 | Péptido señal con actividad de permeabilización de células microbianas; vector; célula huésped; molécula conjugada que lo comprende; y método para permeabilizar una célula microbiana. |
CL2008002860A CL2008002860A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido; polinucleotido que lo codifica; vector y fago aislado que comprenda este polinucleotido; anticuerpo que se une a este polipeptido; molecula de fusion que comprende este polipeptido; celula huesped metanogena que comprende el vector; composicion farmaceutica que comprende el polinucleotido. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008002859A CL2008002859A1 (es) | 2007-09-25 | 2008-09-25 | Péptido señal con actividad de permeabilización de células microbianas; vector; célula huésped; molécula conjugada que lo comprende; y método para permeabilizar una célula microbiana. |
CL2008002860A CL2008002860A1 (es) | 2007-09-25 | 2008-09-25 | Polipeptido; polinucleotido que lo codifica; vector y fago aislado que comprenda este polinucleotido; anticuerpo que se une a este polipeptido; molecula de fusion que comprende este polipeptido; celula huesped metanogena que comprende el vector; composicion farmaceutica que comprende el polinucleotido. |
Country Status (17)
Country | Link |
---|---|
US (7) | US8592556B2 (es) |
EP (5) | EP2203467B1 (es) |
JP (5) | JP5552053B2 (es) |
CN (4) | CN107129524B (es) |
AR (3) | AR068551A1 (es) |
AU (4) | AU2008305846A1 (es) |
BR (5) | BR122021010737B1 (es) |
CA (3) | CA2700162C (es) |
CL (3) | CL2008002861A1 (es) |
DK (3) | DK2203466T3 (es) |
ES (3) | ES2587595T3 (es) |
MX (3) | MX340736B (es) |
NZ (1) | NZ745324A (es) |
RU (1) | RU2528854C2 (es) |
UY (3) | UY31359A1 (es) |
WO (3) | WO2009041831A1 (es) |
ZA (1) | ZA201001933B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5552053B2 (ja) | 2007-09-25 | 2014-07-16 | パストラル グリーンハウス ガス リサーチ リミテッド | ファージφMRUポリヌクレオチドおよびポリペプチドならびにその使用 |
GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
EA037202B1 (ru) | 2009-06-26 | 2021-02-18 | Катхолике Университейт Лёвен, К.У. Лёвен Р Энд Д | Слитые белки для лечения инфекций, вызванных грамотрицательными бактериями |
US20120195872A1 (en) * | 2009-06-26 | 2012-08-02 | Lysando Ag | Antimicrobial agents |
US9441016B2 (en) | 2009-08-27 | 2016-09-13 | Pastoral Greenhouse Gas Research Ltd. | Complete genome sequence of the methanogen Methanobrevibacter ruminantium |
TWI527521B (zh) * | 2010-04-27 | 2016-04-01 | 利山鐸公司 | 減少生物膜的方法 |
TWI655287B (zh) * | 2012-09-19 | 2019-04-01 | 韓商傑姆維克斯&凱爾有限公司 | 穿膜胜肽以及包含該胜肽之共軛物及組成物(三) |
EP3741868B1 (en) | 2013-03-15 | 2024-05-22 | The General Hospital Corporation | Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
US10011850B2 (en) | 2013-06-21 | 2018-07-03 | The General Hospital Corporation | Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing |
CN106459995B (zh) | 2013-11-07 | 2020-02-21 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
AU2015343307B2 (en) * | 2014-11-06 | 2021-05-20 | Iff Us Holding, Llc | Peptide-mediated delivery of RNA-guided endonuclease into cells |
CN104789675A (zh) * | 2015-04-15 | 2015-07-22 | 江苏师范大学 | 一种检测荷斯坦奶牛瘤胃微生物的方法 |
WO2016178207A1 (en) * | 2015-05-04 | 2016-11-10 | Ramot At Tel-Aviv University Ltd. | Methods and kits for fragmenting dna |
US9512446B1 (en) | 2015-08-28 | 2016-12-06 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
BR112018077483A2 (pt) * | 2016-07-14 | 2019-04-02 | Basf Se | meio de fermentação, métodos para cultivar um microrganismo e para produzir um composto de interesse, solução de oligoelemento para um processo de fermentação, e, uso de um agente quelante. |
JP7234114B2 (ja) * | 2016-12-29 | 2023-03-07 | イルミナ インコーポレイテッド | 細胞区画内の生体分子への直交アクセスおよび細胞区画内の生体分子のタグ付けのための分析システム |
WO2018126499A1 (zh) * | 2017-01-05 | 2018-07-12 | 深圳迈瑞生物医疗电子股份有限公司 | 网织红细胞模拟粒子、血小板模拟粒子制备方法及质控物 |
US10745439B2 (en) * | 2017-03-20 | 2020-08-18 | Regents Of The University Of Minnesota | Kinase substrates and methods of use thereof |
US20190233816A1 (en) | 2018-01-26 | 2019-08-01 | Massachusetts Institute Of Technology | Structure-guided chemical modification of guide rna and its applications |
WO2019183123A1 (en) * | 2018-03-19 | 2019-09-26 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems |
CN113677359A (zh) * | 2018-11-14 | 2021-11-19 | 鲁比克治疗股份有限公司 | Cd25抗体 |
CN109627301B (zh) * | 2019-02-18 | 2022-08-05 | 浙江新银象生物工程有限公司 | Nisin固体稳定剂开发及应用 |
CN112143747B (zh) * | 2020-09-09 | 2022-09-13 | 昆明理工大学 | 一种噬菌体裂解酶及其基因、基因重组表达载体与应用 |
JP2023553202A (ja) | 2020-12-08 | 2023-12-20 | ルミナント バイオテク コーポレーション リミテッド | 動物に物質を送達するための装置および方法の改善 |
CN112961217B (zh) * | 2021-03-19 | 2022-11-08 | 江苏元本生物科技有限公司 | 一种靶向Siglec-15的噬菌体多肽 |
CN113121705B (zh) * | 2021-04-19 | 2023-03-24 | 成都英普博集生物科技有限公司 | 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用 |
US20240009291A1 (en) * | 2022-07-11 | 2024-01-11 | Arkea Bio Corp. | Compositions and methods for reducing methane emissions in ruminant populations |
WO2024097397A1 (en) * | 2022-11-03 | 2024-05-10 | Helix Nanotechnologies, Inc. | Ruminal and methanogen vaccines and uses thereof |
CN115938486B (zh) * | 2022-12-06 | 2023-11-10 | 内蒙古农业大学 | 基于图神经网络的抗菌性乳酸菌株筛选方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US159861A (en) * | 1875-02-16 | Improvement in brooms | ||
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
CA1221635A (fr) * | 1983-05-03 | 1987-05-12 | Andre Speecke | Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires |
GB8815968D0 (en) * | 1988-07-05 | 1988-08-10 | Pfizer Ltd | Veterinary devices |
JPH05219927A (ja) * | 1992-02-14 | 1993-08-31 | Gumma Pref Gov | 飼料の混合装置及び混合飼料の製造方法 |
JP3651915B2 (ja) * | 1993-06-30 | 2005-05-25 | 財団法人神奈川科学技術アカデミー | シグナル配列ペプチドをコードするdna断片の探索法及びそのためのベクター |
WO1995011041A1 (en) | 1993-10-19 | 1995-04-27 | Commonwealth Scientific And Industrial Research Organisation | Method for improving utilisation of nutrients by ruminant or ruminant-like animals |
EP0730663B1 (en) | 1993-10-26 | 2003-09-24 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
ATE249816T1 (de) | 1994-01-20 | 2003-10-15 | Agres Ltd | Vorrichtung zur verabreichung von nützlichen stoffen an wiederkäuer |
NZ278977A (en) | 1994-01-20 | 1997-03-24 | Pastoral Agric Res Inst Nz Ltd | Sustained release bolus for ruminants |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
AUPN353695A0 (en) | 1995-06-14 | 1995-07-06 | Commonwealth Scientific And Industrial Research Organisation | Immunogenic preparation and method for improving the productivity of ruminant animals |
US6503729B1 (en) * | 1996-08-22 | 2003-01-07 | The Board Of Trustees Of The University Of Illinois | Selected polynucleotide and polypeptide sequences of the methanogenic archaeon, methanococcus jannashii |
US5985907A (en) * | 1998-08-12 | 1999-11-16 | Health Research, Inc. | Method for inhibiting growth of methanogens |
AU2002306849A1 (en) | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
WO2003038109A2 (en) | 2001-09-18 | 2003-05-08 | The Board Of Regents Of The University Of Nebraska | Method for the inhibition of methanogenesis |
US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
WO2003076575A2 (en) * | 2002-03-04 | 2003-09-18 | Fidelity Systems, Inc., Et Al. | The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
SE523209C2 (sv) * | 2002-05-14 | 2004-04-06 | Akzo Nobel Nv | Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur |
US20100048595A1 (en) | 2005-03-23 | 2010-02-25 | Washington University In St. Louis | Use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota |
JP5552053B2 (ja) * | 2007-09-25 | 2014-07-16 | パストラル グリーンハウス ガス リサーチ リミテッド | ファージφMRUポリヌクレオチドおよびポリペプチドならびにその使用 |
CN101434924A (zh) * | 2008-12-17 | 2009-05-20 | 中南大学 | 一种分离严格厌氧产甲烷古菌的方法 |
US9441016B2 (en) * | 2009-08-27 | 2016-09-13 | Pastoral Greenhouse Gas Research Ltd. | Complete genome sequence of the methanogen Methanobrevibacter ruminantium |
CN101864362B (zh) * | 2010-05-19 | 2012-05-09 | 江苏加德绿色能源有限公司 | 一种复合微生物菌剂及其应用 |
DE102011119230B4 (de) * | 2011-11-23 | 2013-07-11 | Audi Ag | Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte |
JP2016511630A (ja) * | 2012-12-21 | 2016-04-21 | ダニスコ・ユーエス・インク | 代案の下流メバロン酸経路を使用するイソプレン、イソプレノイド、およびイソプレノイド前駆体の生成 |
-
2008
- 2008-09-25 JP JP2010526840A patent/JP5552053B2/ja not_active Expired - Fee Related
- 2008-09-25 CL CL2008002861A patent/CL2008002861A1/es unknown
- 2008-09-25 AR ARP080104171A patent/AR068551A1/es unknown
- 2008-09-25 BR BR122021010737-8A patent/BR122021010737B1/pt active IP Right Grant
- 2008-09-25 BR BRPI0817312-5A patent/BRPI0817312B1/pt active IP Right Grant
- 2008-09-25 DK DK08834203.5T patent/DK2203466T3/en active
- 2008-09-25 CA CA2700162A patent/CA2700162C/en active Active
- 2008-09-25 CN CN201611216760.1A patent/CN107129524B/zh active Active
- 2008-09-25 UY UY31359A patent/UY31359A1/es not_active Application Discontinuation
- 2008-09-25 US US12/678,936 patent/US8592556B2/en active Active
- 2008-09-25 WO PCT/NZ2008/000248 patent/WO2009041831A1/en active Application Filing
- 2008-09-25 CA CA2700129A patent/CA2700129C/en active Active
- 2008-09-25 AR ARP080104172A patent/AR068552A1/es unknown
- 2008-09-25 DK DK17206527.8T patent/DK3327030T3/da active
- 2008-09-25 AU AU2008305846A patent/AU2008305846A1/en not_active Abandoned
- 2008-09-25 MX MX2010003319A patent/MX340736B/es active IP Right Grant
- 2008-09-25 WO PCT/NZ2008/000247 patent/WO2009041830A2/en active Application Filing
- 2008-09-25 BR BRPI0817299A patent/BRPI0817299A8/pt not_active Application Discontinuation
- 2008-09-25 JP JP2010526841A patent/JP6067209B2/ja active Active
- 2008-09-25 AR ARP080104173A patent/AR068553A1/es active IP Right Grant
- 2008-09-25 US US12/678,925 patent/US8586709B2/en active Active
- 2008-09-25 MX MX2010003321A patent/MX2010003321A/es active IP Right Grant
- 2008-09-25 JP JP2010526839A patent/JP5558356B2/ja not_active Expired - Fee Related
- 2008-09-25 UY UY31361A patent/UY31361A1/es active IP Right Grant
- 2008-09-25 EP EP08834643.2A patent/EP2203467B1/en active Active
- 2008-09-25 EP EP08834203.5A patent/EP2203466B1/en active Active
- 2008-09-25 AU AU2008304018A patent/AU2008304018A1/en not_active Abandoned
- 2008-09-25 DK DK08834643.2T patent/DK2203467T3/en active
- 2008-09-25 ES ES08834203.5T patent/ES2587595T3/es active Active
- 2008-09-25 RU RU2010116163/10A patent/RU2528854C2/ru not_active IP Right Cessation
- 2008-09-25 BR BR122020023381-8A patent/BR122020023381B1/pt active IP Right Grant
- 2008-09-25 AU AU2008304019A patent/AU2008304019A1/en not_active Abandoned
- 2008-09-25 EP EP21181143.5A patent/EP3936516A1/en active Pending
- 2008-09-25 UY UY31360A patent/UY31360A1/es not_active Application Discontinuation
- 2008-09-25 EP EP08833501A patent/EP2203470A4/en not_active Ceased
- 2008-09-25 ES ES08834643.2T patent/ES2625144T3/es active Active
- 2008-09-25 ES ES17206527T patent/ES2895908T3/es active Active
- 2008-09-25 CN CN2008801094507A patent/CN102015755A/zh active Pending
- 2008-09-25 CL CL2008002859A patent/CL2008002859A1/es unknown
- 2008-09-25 CN CN200880109156.6A patent/CN101932595B/zh active Active
- 2008-09-25 CA CA2700164A patent/CA2700164C/en active Active
- 2008-09-25 CL CL2008002860A patent/CL2008002860A1/es unknown
- 2008-09-25 NZ NZ745324A patent/NZ745324A/en unknown
- 2008-09-25 US US12/678,976 patent/US9296789B2/en active Active
- 2008-09-25 EP EP17206527.8A patent/EP3327030B1/en active Active
- 2008-09-25 WO PCT/NZ2008/000249 patent/WO2009041832A2/en active Application Filing
- 2008-09-25 CN CN200880109364.6A patent/CN101918431B/zh active Active
- 2008-09-25 BR BR122021010729-7A patent/BR122021010729B1/pt active IP Right Grant
- 2008-09-25 MX MX2010003328A patent/MX2010003328A/es active IP Right Grant
-
2010
- 2010-03-18 ZA ZA2010/01933A patent/ZA201001933B/en unknown
-
2013
- 2013-10-25 US US14/063,640 patent/US20140220636A1/en not_active Abandoned
-
2014
- 2014-07-04 JP JP2014139171A patent/JP2015042166A/ja active Pending
- 2014-08-08 AU AU2014210649A patent/AU2014210649B2/en active Active
-
2016
- 2016-03-28 US US15/082,373 patent/US10590170B2/en active Active
- 2016-10-05 JP JP2016197575A patent/JP2017046704A/ja active Pending
-
2020
- 2020-02-10 US US16/786,665 patent/US10995120B2/en active Active
-
2021
- 2021-04-08 US US17/226,028 patent/US11926647B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008002861A1 (es) | Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion. | |
BR112012011740A2 (pt) | polipeptídeo, composição compreendendo o referido polipeptídeo, complexo de proteína, seqüência de nucleotídeo, vetor de expressão célula, e métodos para a preparação do complexo de proteína, para a preparação de um fviii, e para intensificar uma propriedade farmacocinética no plasma de um fviii | |
PE20091382A1 (es) | Anticuerpos que se une a il-4 y/o a il-13 | |
BR112012009854B8 (pt) | proteína de ligação de antígeno isolada recombinante que liga il-23, composição farmacêutica, molécula de ácido nucleico isolada recombinante, vetor recombinante, método de confecção da referida proteína de ligação e uso da mesma | |
CL2009000459A1 (es) | Anticuerpo se une a la proteina rgm a; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; construccion de anticuerpos que comprende dicha proteina; conjugado de anticuerpos que comprende a la construccion; uso. | |
CR10652A (es) | Anticuerpos monoclonales humanos especificos para light humano antagonistas | |
PE20091713A1 (es) | Inhibicion del receptor para la proteina estimulante del macrofago (ron), composiciones y metodos | |
CR9969A (es) | Anticuerpos anti-globulomero ab, porciones de union a antigeno de estos, hibridomas correspondientes, acidos nucleicos, vectores, celulas huesped, metodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos | |
MX347295B (es) | Inmunoglobulinas portadoras y usos de las mismas. | |
CL2008001814A1 (es) | Anticuerpos anti-factor de crecimiento 1 y 2 semejantes a insulina (igf-1, igf-2); molecula de adn que los codifica; vector y celula huesped; metodo de produccion; composicion farmaceutica que los comprende; y su uso para tratar cancer. | |
AR071874A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
NZ595707A (en) | Cancer antigen helper peptide | |
CO6280541A2 (es) | Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40 | |
BR112016014913A8 (pt) | anticorpo, ou um fragmento de ligação ao antígeno do mesmo, conjugado, ácido nucléico, vetor, célula hospedeira, composição farmacêutica, método de preparo de uma cadeia leve de um anticorpo ou fragmento de ligação ao antígeno e método de preparo de um conjugado | |
UA97516C2 (ru) | Полностью человеческое моноклональное антитело против vap-1 | |
CL2010001457A1 (es) | Molecula de acido nucleico que codifica delta endotoxinas de bacillus thuringiensis; constituciones moleculares quer comprenden dichos polinucleotifdos, anticuerpos que se asocian especificamente a las endotoxinas, y procedimiento para el control de plagas de insectos. | |
BR112012026766A2 (pt) | métodos in vitro para gerar uma proteína heterodimérica, para a seleção de um anticorpo biespecífico e para inibir o crescimento, vetor de expressão, célula hospedeira, proteína heterodimérica, composição farmacêutica. | |
DE602005026219D1 (de) | Gegen das säugetier-eag1-ionenkanalprotein gerichtete antikörper | |
ES2674567T3 (es) | Proteínas de fusión biespecíficas | |
BR112012005713A2 (pt) | vacinas direcionadas a célula langerhans. | |
MX2016011934A (es) | Inmunoglobulina hibrida conteniendo un enlace no-peptidilico. | |
AR047729A1 (es) | Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe) | |
AU2011353197A8 (en) | A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis | |
AR079340A1 (es) | Anticuerpos anti-c4.4a y usos de los mismos | |
DE602006018424D1 (de) | Peptide zum nachweis von ehrlichia ewingii antikörper |